Dysphagia Screening for Pneumonia Prevention in a Cancer Hospital: Results of a Quality/Safety Initiative.


Journal

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176

Informations de publication

Date de publication:
02 2020
Historique:
pubmed: 4 12 2019
medline: 1 7 2020
entrez: 4 12 2019
Statut: ppublish

Résumé

Hospital-acquired aspiration pneumonia remains a rare but potentially devastating problem. The best means by which to prevent aspiration in a cancer hospital population has not been evaluated. The aim of this study was to evaluate the impact of dysphagia screening on aspiration pneumonia rates in an acute care oncology hospital. A prospective single-institution quality improvement dysphagia screening protocol at a comprehensive cancer center. Effect of dysphagia screening implemented in 2016 on hospital-acquired aspiration pneumonia rates coded "aspiration pneumonitis due to food/vomitus" was compared with rates from 2014 to 2015 prior to implementation. Screening compliance, screening outcomes, patient demographics, and medical data were reviewed as part of a post hoc analysis. Of 12,392 admissions in 2014 to 2016, 97 patients developed aspiration pneumonia during their hospitalization. No significant change in aspiration pneumonia rate was seen during the dysphagia screening year when compared to prior years (baseline, 7.36; screening year, 8.78 per 1000 discharges; Nursing-initiated dysphagia screening did not decrease aspiration pneumonia rates. The causes of aspiration-associated pneumonia were heterogeneous. Aspiration of intestinal contents is a more common source of hospital-acquired pneumonia than oropharyngeal dysphagia.

Identifiants

pubmed: 31791195
doi: 10.1177/0194599819889893
pmc: PMC7723302
mid: NIHMS1633834
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-229

Subventions

Organisme : NCI NIH HHS
ID : P30 CA006927
Pays : United States

Références

Age Ageing. 2016 Jan;45(1):171-4
pubmed: 26683049
JAMA Surg. 2013 Aug;148(8):740-5
pubmed: 23740240
J Nutr Health Aging. 2016;20(8):806-815
pubmed: 27709229
PLoS One. 2017 Nov 14;12(11):e0188167
pubmed: 29135994
Curr Opin Crit Care. 2018 Oct;24(5):370-378
pubmed: 30015635
J Clin Nurs. 2014 Jul;23(13-14):1908-15
pubmed: 24033866
Antimicrob Resist Infect Control. 2016 Nov 14;5:43
pubmed: 27895901
Am J Infect Control. 2018 Mar;46(3):322-327
pubmed: 29050905
Ann Intern Med. 2006 Apr 18;144(8):575-80
pubmed: 16618955
Ann Otol Rhinol Laryngol. 2007 Nov;116(11):858-65
pubmed: 18074673
Thorac Surg Clin. 2015 Aug;25(3):301-7
pubmed: 26210926
Am J Infect Control. 2014 Jan;42(1):38-42
pubmed: 24199911
Dysphagia. 1998 Spring;13(2):69-81
pubmed: 9513300
Curr Opin Pulm Med. 2015 May;21(3):260-71
pubmed: 25784246
Dysphagia. 2014 Apr;29(2):199-203
pubmed: 24026519
Ann Am Thorac Soc. 2013 Oct;10(5):493-5
pubmed: 24161051
J Korean Med Sci. 2011 Aug;26(8):979-84
pubmed: 21860545
Age Ageing. 2010 Jan;39(1):39-45
pubmed: 19561160
JAMA. 2009 Dec 2;302(21):2323-9
pubmed: 19952319
Ann Otol Rhinol Laryngol. 2014 Sep;123(9):629-35
pubmed: 24707011
Support Care Cancer. 2015 Nov;23(11):3249-55
pubmed: 25832897
Stroke. 2017 Sep;48(9):2583-2585
pubmed: 28716980
Am J Infect Control. 2012 Jun;40(5):396-407
pubmed: 21908073
Infect Control Hosp Epidemiol. 2016 Jul;37(7):818-24
pubmed: 27072043
J Periodontol. 2006 Sep;77(9):1465-82
pubmed: 16945022
J Oncol Pract. 2017 Jul;13(7):426-434
pubmed: 28697317
Chest. 2016 Nov;150(5):1008-1014
pubmed: 27102181
Respiration. 2009;78(4):416-22
pubmed: 19648731
Anaesthesia. 1999 Jan;54(1):19-26
pubmed: 10209365
Support Care Cancer. 2012 Mar;20(3):433-43
pubmed: 22205548
J Neurosci Nurs. 2016 Jul-Aug;48(4):215-23
pubmed: 27224683

Auteurs

Barbara Ebersole (B)

Department of Otolaryngology-Head & Neck Surgery, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Speech Pathology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania, USA.

Miriam Lango (M)

Department of Otolaryngology-Head & Neck Surgery, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Surgical Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania, USA.

John Ridge (J)

Department of Otolaryngology-Head & Neck Surgery, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Surgical Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania, USA.

Elizabeth Handorf (E)

Department of Biostatistics, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania, USA.

Jeffrey Farma (J)

Department of Surgical Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania, USA.

Sarah Clark (S)

Department of Otolaryngology-Head & Neck Surgery, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Speech Pathology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania, USA.

Nausheen Jamal (N)

Department of Surgery, University of Texas Rio Grande Valley School of Medicine, University of Texas Health, Edinburg, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH